AU467306B2 - 15, 16-methylene-4-oestren-17 -ols - Google Patents

15, 16-methylene-4-oestren-17 -ols

Info

Publication number
AU467306B2
AU467306B2 AU52076/73A AU5207673A AU467306B2 AU 467306 B2 AU467306 B2 AU 467306B2 AU 52076/73 A AU52076/73 A AU 52076/73A AU 5207673 A AU5207673 A AU 5207673A AU 467306 B2 AU467306 B2 AU 467306B2
Authority
AU
Australia
Prior art keywords
oestren
ols
methylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU52076/73A
Other versions
AU5207673A (en
Inventor
WIECHERT HERMANN STEINBECK and WALTER ELGER RUDOLF
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5207673A publication Critical patent/AU5207673A/en
Application granted granted Critical
Publication of AU467306B2 publication Critical patent/AU467306B2/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU52076/73A 1972-02-11 1973-02-12 15, 16-methylene-4-oestren-17 -ols Expired AU467306B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (en) 1972-02-11 1972-02-11 15?, 16? -Methylene-4-oestrene-17? -ols or acylates, processes for their production and medicaments containing them
DEDE82207 1972-02-16

Publications (2)

Publication Number Publication Date
AU5207673A AU5207673A (en) 1974-08-15
AU467306B2 true AU467306B2 (en) 1975-11-27

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52076/73A Expired AU467306B2 (en) 1972-02-11 1973-02-12 15, 16-methylene-4-oestren-17 -ols

Country Status (29)

Country Link
JP (1) JPS5829317B2 (en)
KR (1) KR780000156B1 (en)
AT (1) AT327413B (en)
AU (1) AU467306B2 (en)
BE (1) BE795241A (en)
CA (1) CA997753A (en)
CH (2) CH590883A5 (en)
CS (1) CS193019B2 (en)
DD (1) DD102379A5 (en)
DE (1) DE2207421C3 (en)
DK (1) DK131037B (en)
EG (1) EG10914A (en)
ES (1) ES410933A1 (en)
FI (1) FI52225C (en)
FR (1) FR2181719B1 (en)
GB (1) GB1425636A (en)
GR (1) GR63160B (en)
HU (1) HU165253B (en)
IE (1) IE37266B1 (en)
IL (1) IL41506A (en)
NL (1) NL177217C (en)
NO (2) NO140304C (en)
PH (1) PH9370A (en)
PL (1) PL81084B1 (en)
RO (1) RO73527A (en)
SE (3) SE403781B (en)
SU (1) SU513628A3 (en)
YU (1) YU35035B (en)
ZA (1) ZA73944B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027636A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-Cyano-18α-homo-19-nor-androst-4-ene derivative, its use and the derivative-containing drug
DE102007027637A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-cyano-19-nor-androst-4-ene derivative, its use and the derivative-containing drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (en) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stackable, rectangular, closed plastic transport container for fine-grained bulk goods and liquids

Also Published As

Publication number Publication date
DD102379A5 (en) 1973-12-12
DE2207421A1 (en) 1973-08-16
FR2181719B1 (en) 1975-11-21
NO143065B (en) 1980-09-01
JPS5829317B2 (en) 1983-06-22
SE409329B (en) 1979-08-13
FR2181719A1 (en) 1973-12-07
NL177217C (en) 1985-08-16
YU35035B (en) 1980-06-30
NO143065C (en) 1980-12-10
FI52225C (en) 1977-07-11
FI52225B (en) 1977-03-31
RO73527A (en) 1982-02-01
NO782754L (en) 1973-08-14
ATA112473A (en) 1975-04-15
IL41506A0 (en) 1973-04-30
SE7713896L (en) 1977-12-07
IE37266B1 (en) 1977-06-08
NL177217B (en) 1985-03-18
SE7514513L (en) 1975-12-22
ZA73944B (en) 1973-11-28
ES410933A1 (en) 1976-03-01
CS193019B2 (en) 1979-09-17
CH590883A5 (en) 1977-08-31
CH593995A5 (en) 1977-12-30
CA997753A (en) 1976-09-28
IL41506A (en) 1976-07-30
NO140304C (en) 1979-08-08
SE403781B (en) 1978-09-04
GR63160B (en) 1979-09-25
JPS4886856A (en) 1973-11-15
NL7301974A (en) 1973-08-14
NO140304B (en) 1979-04-30
AT327413B (en) 1976-01-26
KR780000156B1 (en) 1978-05-02
DE2207421B2 (en) 1980-07-24
DK131037C (en) 1975-10-20
GB1425636A (en) 1976-02-18
PH9370A (en) 1975-10-22
YU24373A (en) 1979-12-31
DK131037B (en) 1975-05-20
AU5207673A (en) 1974-08-15
SE426834B (en) 1983-02-14
EG10914A (en) 1976-09-30
BE795241A (en) 1973-08-09
PL81084B1 (en) 1975-08-30
SU513628A3 (en) 1976-05-05
HU165253B (en) 1974-07-27
DE2207421C3 (en) 1981-05-07
IE37266L (en) 1973-08-11

Similar Documents

Publication Publication Date Title
CA1011741A (en) 5,6,7,8-tetrahydroquinoline-8-thiocarboxamides and related compounds
CA1012534A (en) 2,6-diaminonebularine derivatives
CA960666A (en) 1-aminomethyl-2,2-diaryl-cyclo-propanecarboxamides
CA1000274A (en) Diacyl-5,6,11,12-tetrahydro-dibenzo(b,f) (1,4) diazocines
CA993452A (en) 2,6-dihalo-4-cyanophenoxy-acetonitriles
CA1024149A (en) 4.alpha.-ARYL-TRANS-DECAHYDROISOQUINOLINES
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1013742A (en) Azabenzo-1,5-diazepines
CA1020953A (en) 2,2,3-endo-trimethyl-7-anti-amino-norbornanes
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
CA999595A (en) 3,5-dialkyl-4-hydroxybenzyl-oxiranes and -thiiranes
AU472337B2 (en) 11, 12-secoprostaglandins
AU474523B2 (en) Substituted 9,10-dihydroanthracenes
AU469505B2 (en) 1,4-ethano-2,3-dihydroquinoline derivatives
AU467008B2 (en) d, d-DIARYLIMIDAZOLE-2-METHANOLS
CA986936A (en) 2,3,5-substituted-6-trifluoromethyl-1,3-diazin-4-ones
CA987669A (en) 10,11-anhydroerythromycins
CA990280A (en) 5,6-trans-25-hydroxycholecalciferol
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA895310A (en) 1,2,4-triazine-5-ones
CA902063A (en) 1,2,8,9-tetraazaphenalene-3-hydrazones
CA900975A (en) 8,5 - amino - substituted-tetrahydrohalo-sulfamyl-quinazolinones
CA917160A (en) 1,4-oxathiins
CA905931A (en) 3,4-diazapregnanes
AU485879B2 (en) 3-diazine-substituted 1, 2, 4-benzothiadiazines